What Researchers Did
Researchers reviewed the potential benefits of adjunctive hyperbaric oxygen therapy (HBOT) for patients with infective endocarditis (IE).
What They Found
This review highlighted the potential beneficial aspects of adjunctive HBOT in IE by summarizing its mechanisms related to infection and inflammation. They noted that two preclinical animal studies demonstrated a beneficial effect of HBOT in IE, though no clinical studies have yet evaluated its feasibility.
What This Means for Canadian Patients
For Canadian patients with infective endocarditis, this review suggests that adjunctive hyperbaric oxygen therapy (HBOT) could potentially offer a new treatment option to improve outcomes. However, more research is needed before HBOT can be routinely considered for clinical use in this patient group.
Canadian Relevance
This review article does not have a direct Canadian connection.
Study Limitations
A significant limitation is the current lack of well-designed clinical studies evaluating the efficacy and feasibility of hyperbaric oxygen therapy in patients with infective endocarditis.